Venus Concept Inc. (VERO): Price and Financial Metrics
VERO Price/Volume Stats
|Current price||$2.10||52-week high||$11.70|
|Prev. close||$2.13||52-week low||$2.06|
|Day high||$2.14||Avg. volume||28,768|
|50-day MA||$2.84||Dividend yield||N/A|
|200-day MA||$4.29||Market Cap||11.46M|
VERO Stock Price Chart Interactive Chart >
VERO Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for VERO is -59.82 -- better than just 0.45% of US stocks.
- With a price/sales ratio of 0.14, VENUS CONCEPT INC has a higher such ratio than just 3.75% of stocks in our set.
- In terms of volatility of its share price, VERO is more volatile than 99.44% of stocks we're observing.
- Stocks that are quantitatively similar to VERO, based on their financial statements, market capitalization, and price volatility, are YAYO, GRPN, MRAI, TRIB, and AVAH.
- Visit VERO's SEC page to see the company's official filings. To visit the company's web site, go to www.venusconcept.com.
VERO Valuation Summary
- In comparison to the median Healthcare stock, VERO's price/earnings ratio is 101.24% lower, now standing at -0.3.
- Over the past 68 months, VERO's price/sales ratio has gone down 13.7.
Below are key valuation metrics over time for VERO.
VERO's Quality FactorsThe “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
- VERO has a Quality Grade of C, ranking ahead of 56.31% of graded US stocks.
- VERO's asset turnover comes in at 0.629 -- ranking 64th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows VERO's key quality metrics over time.
|Period||Asset Turnover||Gross Margin||ROIC|
VERO Price Target
For more insight on analysts targets of VERO, see our VERO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
|Average Price Target||$5.55||Average Broker Recommendation||1.3 (Strong Buy)|
Venus Concept Inc. (VERO) Company Bio
Venus Concept Inc. (formerly Restoration Robotics, Inc.), a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. It offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. The company was founded in 2002 and is based in San Jose, California.
VERO Latest News Stream
|Loading, please wait...|
VERO Latest Social Stream
View Full VERO Social Stream
Latest VERO News From Around the Web
Below are the latest news stories about VENUS CONCEPT INC that investors may wish to consider to help them evaluate VERO as an investment opportunity.
Venus Concept Announces First Quarter of Fiscal Year 2023 Financial Results
TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2023. First Quarter 2023 Summary & Recent Highlights: Company continues to execute against Transformational Plan Total revenue of $20.5 million, down $5.9 million, or 22%, year-over-yearCash system revenue represented approximately 66% of total systems and subscriptions revenu
Venus Concept Inc. Announces Multi-Tranche Private Placement of Senior Convertible Preferred Stock for up to $9 Million with EW Healthcare Partners
TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into a stock purchase agreement (the “Stock Purchase Agreement”) with funds affiliated with EW Healthcare Partners (the “Investors”). Pursuant to the Stock Purchase Agreement, the Company may issue and sell to the Investors up to $9,000,000, before offering expenses, in shares of senior convertible prefer
Venus Concept Announces 1-for-15 Reverse Stock Split
TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that its Board of Directors approved a 1-for-15 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 5:00 p.m. Eastern Daylight Time today. The Company’s common stock is expected to begin trading on The Nasdaq Capital Market on a sp
Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023. Management will host a conference call at 8:00 a.m. Eastern Time on May 15, 2023 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 8
Venus Concept Inc. (NASDAQ:VERO) Q4 2022 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q4 2022 Earnings Call Transcript March 27, 2023 Operator: Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that […]
VERO Price Returns
Loading social stream, please wait...